Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery
PEG
1 other identifier
interventional
20
1 country
1
Brief Summary
The main objective is to evaluate the impact of intestinal preparation on the composition, diversity and metabolome of the intestinal microbiota.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1 cancer
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2024
CompletedFirst Submitted
Initial submission to the registry
February 13, 2025
CompletedFirst Posted
Study publicly available on registry
February 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 5, 2026
February 19, 2025
February 1, 2025
1.7 years
February 13, 2025
February 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the impact of bowel preparation on the gut microbiota at 1 week after bowel preparation.
Study of the gut microbiota composition at 1 week after bowel preparation.
At week 1
Secondary Outcomes (1)
Gut microbiome composition, diversity, and gut metabolome profile at 1 month and 3 months after bowel preparation
At 1 month and 3 months
Study Arms (1)
Healthy volunteer participant cohort
EXPERIMENTALFor healthy volunteer participants, PEG bowel preparation will be administered and participants will collect stool samples before and after PEG at specified timepoints.
Interventions
Volunteers will be administered 4L of PEG bowel preparation. The following instructions will be provided with the prescription: 1. Fill the supplied container containing the bowel cleanse powder with lukewarm water (to facilitate dissolution) to the 4-liter fill line. The solution is clear and colourless when reconstituted to a final volume of 4 liters. 2. After capping the container, shake vigorously several times to ensure that the ingredients are dissolved. The solution is more palatable if chilled prior to drinking. When reconstituted use within 48 hours. 3. Attempt to drink a maximum of 4 liters at a rate of 240 mL (8 oz.) every 10 minutes, until 4 liters has been consumed or the rectal effluent is clear. Rapid drinking of each portion is preferred to drinking small amounts continuously. 4. The first bowel movements should occur approximately one hour after the start of bowel cleanse administration. Continue drinking until the watery stool is clear and free of solid matter.
Eligibility Criteria
You may qualify if:
- Healthy volunteer participant cohort:
- \> 18 years of age
- The participant has provided documented informed consent for the participation and to complete PEG bowel preparation and return collected stool samples.
You may not qualify if:
- An ileus
- Significant gastric retention
- Suspected or established mechanical bowel obstruction
- Inflammatory or infectious gastrointestinal condition
- Neurologic or cognitive impairment that prevents safe swallowing
- Recent history (\<1 year) of cancer that still requires ongoing treatment
- Recent use of antibiotics 1 month prior to participation in the trial
- History of cardiac disease
- History of active renal dysfunction
- Presence of any absolute contraindication to PEG bowel preparation according to manufacturer labeling
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, H2X 3E4, Canada
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Arielle Elkrief, MD
Centre hospitalier de l'Université de Montréal (CHUM)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2025
First Posted
February 18, 2025
Study Start
December 5, 2024
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 5, 2026
Last Updated
February 19, 2025
Record last verified: 2025-02